Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted
Seattle, Washington
Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted Clinical Trials in Seattle, Washington
1 recruiting
Seattle, Washington
Showing
1–1
of
1
trials
Recruiting
Phase 3
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Glioma
Astrocytoma, IDH-Mutant, Grade 2
Astrocytoma, Grade IV
+5 more
Nuvation Bio Inc.
365 enrolled
45 locations
NCT05303519
Feedback